Wolfe Zachary, Lash Bradley
Department of Internal Medicine, Guthrie Clinic/Robert Packer Hospital, Sayre, PA, USA.
Department of Hematology and Oncology, Guthrie Clinic/Robert Packer Hospital, Sayre, PA, USA.
Case Rep Hematol. 2017;2017:9862620. doi: 10.1155/2017/9862620. Epub 2017 May 29.
Acquired von Willebrand syndrome (AVWS) is an increasingly recognized entity with numerous potential underlying etiologies. Most commonly implicated are lymphoproliferative, myeloproliferative, cardiovascular, and autoimmune disorders. Unlike inherited von Willebrand disease (vWD), AVWS tends to present at an older age and without a family history of vWD. Treatment is directed at the underlying etiology if one is uncovered, as well as treatment and prevention of bleeding. Here, we present a rare case of AVWS secondary to Waldenström macroglobulinemia which went unrecognized for several years but resolved promptly with treatment. The potential mechanisms of AVWS secondary to monoclonal gammopathies are discussed as well as strategies to treat and prevent bleeding in these patients.
获得性血管性血友病综合征(AVWS)是一种日益被认识的疾病,有众多潜在的病因。最常涉及的是淋巴增殖性、骨髓增殖性、心血管和自身免疫性疾病。与遗传性血管性血友病(vWD)不同,AVWS往往在较年长时出现,且无vWD家族史。如果发现了潜在病因,治疗将针对该病因,同时进行出血的治疗和预防。在此,我们报告一例继发于华氏巨球蛋白血症的罕见AVWS病例,该病例多年未被识别,但经治疗后迅速缓解。本文讨论了单克隆丙种球蛋白病继发AVWS的潜在机制以及这些患者出血的治疗和预防策略。